Our Resources | Association for Accessible Medicines

AAM All Access Podcast - Dan Leonard speaks to David Gaugh (AAM), Jessica Daley (Premier Inc) and Steven Schondelmeyer (University of Minnesota).

Video

May 24, 2022 | Erica Klinger

Sandoz US Leadership on the Value and Promise of #RemarkablyGeneric

Ariel with Medicines

May 23, 2022 | Allen Goldberg

AAM Statement in Response to Federal Trade Commission Request for Information on PBM Business Practices

Ariel with Medicines

May 23, 2022 | Monét Stanford

AAM Calls for Federal Trade Commission to Investigate PBM Business Practices

May 16, 2022 | Allen Goldberg

Association for Accessible Medicines Names Craig Burton as Senior Vice President, Policy & Strategic Alliances, and Executive Director of the Biosimilars Council

Headquarter of the U.S. Food and Drug Administration (FDA)

May 11, 2022 | Allen Goldberg

AAM Statement on House Energy and Commerce Health Subcommittee Markup of H.R. 7667 Reauthorizing Generic Drug and Biosimilar User Fee Amendments

IQVIA The Use of Medicines in the U.S. 2022 Report

May 2, 2022 | Monét Stanford

Generics Drive Savings Yet Patients Continue to Pay More

Video

Apr 28, 2022 | Erica Klinger

GRx+Biosims 2022

Healthcare charts

Apr 19, 2022 | Monét Stanford

As Health Care Spending in US Projected to Increase, Generics and Biosimilars Expected to Moderate Growth

The Medicare prescription drug program (Part D): Status report

Apr 19, 2022 | Monét Stanford

Challenges & Solutions for Prescription Drug Savings Identified by MedPAC

Apr 8, 2022 | Steven Selde

HHS OIG Report Demonstrates Need for Changes to Part D to Increase Biosimilar Use

Apr 1, 2022 | Rachel Schwartz

HHS Finds Biosimilars Use Results in “Significant Spending Reduction” For Medicare and Its Beneficiaries

KC, 73, Seattle, WA | High blood pressure / High cholesterol

Mar 30, 2022 | Erica Klinger

KC is Enjoying Life— “a Pretty Good Deal” on Prescriptions